[1] SINGH A,MANN H S,THUKRAL C L,et al. Diagnostic accuracy of MRCP as compared to ultrasound/CT in patients with obstructive jaundice[J]. J Clin Diagn Res,2014,8(3):103-107.
[2] CHALYA P L,KANUMBA E S,MCHEMBE M. Etiological spectrum and treatment outcome of obstructive jaundice at a university teaching hospital in northwestern Tanzania:a diagnostic and therapeutic challenges[J]. BMC Res Notes,2011,4:147.
[3] 金龙,邹英华. 梗阻性黄疸经皮肝穿刺胆道引流及支架植入术专家共识(2018)[J]. 中国介入影像与治疗学,2019,16(1):2-7.
[4] LI J,ZHUO S,CHEN B,et al. Clinical efficacy of laparoscopic modified loop cholecystojejunostomy for the treatment of malignant obstructive jaundice[J]. J Int Med Res,2020,48(2):1219665837.
[5] WANG L,YU W F. Obstructive jaundice and perioperative management[J]. Acta Anaesthesiol Taiwan,2014,52(1):22-29.
[6] 王君璞,张永康,徐钧. 胆管结石阻塞性黄疸患者术后应用自拟化湿柴平汤的疗效探析[J]. 中外医疗,2015(12):163-164.
[7] HANIF H,KHAN S A,MUNEER S,et al. Diagnostic accuracy of ultrasound in evaluation of obstructive jaundice with MRCP as gold standard[J]. Pak J Med Sci,2020,36(4):652-656.
[8] NEHEZ L,ANDERSSON R. Compromise of immune function in obstructive jaundice[J]. Eur J Surg,2002,168(6):315-328.
[9] 江涛,朱永康. 梗阻性黄疸围手术期细胞免疫功能障碍发生机制研究进展[J]. 世界华人消化杂志,2007(9):991-993.
[10] KONDELKOVA K,VOKURKOVA D,KREJSEK J,et al. Regulatory T cells(TREG) and their roles in immune system with respect to immunopathological disorders[J]. Acta Medica(Hradec Kralove),2010, 53(2):73-77.
[11] 陈秋源,钟小生,谭志健. 梗阻性黄疸的中西医治疗进展[J]. 现代中西医结合杂志,2016,25(2):221-225.
[12] 刘军舰,李忠廉,张西波. 利胆扶正颗粒对恶性阻塞性黄疸患者外周血CD4+CD25+ 调节性T细胞水平的影响[J]. 辽宁中医杂志,2013,40(6):1065-1067.
[13] 江帆,孙权,吴国俊,等. 不同引流方式对恶性梗阻性黄疸患者细胞免疫的影响[J]. 临床外科杂志,2016,24(10):760-763.
[14] FADAHUNSI O O,IBITOYE B O,ADISA A O,et al. Diagnostic accuracy of ultrasonography in adults with obstructive jaundice[J]. J Ultrason,2020,20(81):e100-e105.
[15] 蔡小蓉,杨建云,肖炳坤,等. 茵陈五苓散的药理及临床研究进展[J]. 中国临床药理学杂志,2017,33(9):857-860.
[16] 王开霞,郑超,朱晓骏,等. 茵陈五苓散治疗胆汁淤积研究进展[J]. 陕西中医,2019,40(12):1822-1824.
[17] 刘艳玲,袁娟,郭敏,等. 基于TLR4/MyD88/NF-κB信号通路探讨黄芪多糖对肺癌小鼠免疫功能的影响及对Th1/Th2的调节作用[J]. 中国免疫学杂志,2021,37(6) :676-682.
[18] 李延光,邹声泉. 当归对阻塞性黄疸患者淋巴细胞IL-2活性和IL-2R表达的影响[J]. 中国普外基础与临床杂志,2007(4):456-458.
[19] 杨秀竹,孙静文,李继坤. 利胆扶正颗粒对梗阻性黄疸患者术后细胞免疫功能的调节[J]. 天津中医药,2006,23(1):27-28.
[20] EHTESHAMFAR S M,AKHBARI M,AFSHARI J T,et al. Anti-inflammatory and immune-modulatory impacts of berberine on activation of autoreactive T cells in autoimmune inflammation[J]. J Cell Mol Med,2020,24(23):13573-13588.
[21] TAO J H,CHENG M,TANG J P,et al. Foxp3,Regulatory T cell,and autoimmune diseases[J]. Inflammation,2017,40(1):328-339.
[1]姜海波,王俊梅,刘贯华.ERCP治疗胆总管结石合并肝硬化的效果分析[J].天津医科大学学报,2018,24(02):162.
JIANG Hai-bo,WANG Jun-mei,LIU Guan-hua.Effect of ERCP in the treatment of common bile duct stones complicated with cirrhosis[J].Journal of Tianjin Medical University,2018,24(01):162.
[2]陈帅,刘军舰,尚海涛,等.基于网络药理学、分子对接及实验探讨茵陈蒿汤调节阻塞性黄疸氧化应激的作用机制[J].天津医科大学学报,2021,27(06):595.
CHEN Shuai,LIU Jun-jian,SHANG Hai-tao,et al.Based on network pharmacology,molecular docking,and experiments to explore the mechanism of Yinchenhao Decoction in regulating oxidative stress of obstructive jaundice[J].Journal of Tianjin Medical University,2021,27(01):595.
[3]孙一萌,刘浩,刘军舰,等.茵陈蒿汤对阻塞性黄疸大鼠肝细胞ATF6/GRP78/CHOP凋亡信号通路的影响[J].天津医科大学学报,2023,29(03):252.
SUN Yi-meng,LIU Hao,LIU Jun-jian,et al.Influence of Yinchenhao decoction on the expression of ATF6/GRP78/CHOP apoptotic signaling pathway in hepatocyte of rats with obstructive jaundice[J].Journal of Tianjin Medical University,2023,29(01):252.
[4]缪道玉,于方海 综述,张西波 审校.调节性细胞死亡方式参与阻塞性黄疸引起肝细胞损伤的机制研究[J].天津医科大学学报,2024,30(04):377.[doi:10.20135/j.issn.1006-8147.2024.04.0377]